Company Guard Therapeutics International AB
Equities
GUARD
SE0021181559
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
30.4 SEK | +1.33% | +1.33% | -15.08% |
Business Summary
Number of employees: 11
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 48 | 30/11/18 | |
Karin Botha
DFI | Director of Finance/CFO | 51 | 13/09/20 |
Michael Reusch
CTO | Chief Tech/Sci/R&D Officer | 64 | 31/12/21 |
Sara Thuresson
CTO | Chief Tech/Sci/R&D Officer | 48 | 23/05/21 |
Torbjörn Larsson
PRN | Corporate Officer/Principal | - | 30/04/22 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Johan Bygge
CHM | Chairman | 68 | 30/04/21 |
Göran Forsberg
BRD | Director/Board Member | 61 | 28/05/19 |
Fredrik Lehmann
BRD | Director/Board Member | 48 | 30/11/22 |
Lars Höckenström
BRD | Director/Board Member | 68 | 22/10/19 |
Johannes Hulthe
BRD | Director/Board Member | 54 | 28/05/19 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 10,061,615 | 6,073,904 ( 60.37 %) | 0 | 60.37 % |
Company contact information
Guard Therapeutics International AB
Nybrogatan 34 2nd Floor
114 39, Stockholm
+46 86 70 65 51
http://www.guardtherapeutics.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-15.08% | 28.15M | |
+23.37% | 47.02B | |
+48.83% | 41.86B | |
-0.94% | 41.76B | |
-5.86% | 28.8B | |
+11.29% | 26.05B | |
-20.92% | 19.15B | |
+3.20% | 12.55B | |
-2.67% | 11.82B | |
+30.23% | 12.34B |
- Stock Market
- Equities
- GUARD Stock
- Company Guard Therapeutics International AB